The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
نویسندگان
چکیده
منابع مشابه
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
PURPOSE To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by randomization. Twelve eyes in each group completed 6 months of regular follow-up and were ultimately included in this study. Each patient was assessed using best corrected visual ...
متن کاملIntravitreal bevacizumab in central serous chorioretinopathy.
OBJECTIVE To evaluate the effect of intravitreal bevacizumab injection in patients with central serous chorioretinopathy (CSCR). STUDY DESIGN Quasi-experimental study. PLACE AND DURATION OF STUDY Layton Rehmatullah Benevolent Trust Eye and Cancer Hospital, Lahore, from July 2010 to April 2011. METHODOLOGY There were 43 eyes of 32 adult patients with CSCR. Patients with choroidal neovascul...
متن کاملIntravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect.
AIMS To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy. METHODS Ten eyes of 10 patients with acute central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits patients had best corrected visual acuity (BCVA), IOP assessment, dilated fund...
متن کاملIntravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intravitreal injection of bevacizumab. To our knowledge, we report the first case of PDT-treated CSC ...
متن کاملAcute Central Serous Chorioretinopathy
PURPOSE To evaluate the influence of clinical and multimodal imaging parameters on the duration of acute central serous chorioretinopathy (CSCR) episodes. METHODS Consecutive patients with first, treatment-naïve central serous chorioretinopathy episodes presenting within 20 days of symptoms onset were prospectively included. They were reevaluated 15 days to 20 days later, followed by monthly ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean Journal of Ophthalmology
سال: 2010
ISSN: 1011-8942
DOI: 10.3341/kjo.2010.24.3.155